- Home
- MX vs QTTB Comparison
MX vs QTTB Comparison
Compare MX & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MX | QTTB |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.4M | 92.8M |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MX | QTTB |
|---|---|---|
| Price | $3.93 | $5.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $5.75 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 1.9M | 260.7K |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.06 | ★ 136.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $178,860,000.00 | $53,737,000.00 |
| Revenue This Year | $8.55 | N/A |
| Revenue Next Year | $6.37 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $1.40 |
| 52 Week High | $5.64 | $8.05 |
Technical Indicators
Market Signals| Indicator | MX | QTTB |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 46.90 |
| Support Level | $2.66 | $4.59 |
| Resistance Level | $5.64 | $7.69 |
| Average True Range (ATR) | 0.55 | 0.61 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 35.23 | 27.85 |
Price Performance
Historical ComparisonAbout MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About QTTB Q32 Bio Inc.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).